UPM Pharmaceuticals, a CDMO focused on solid oral and semi-solid dosage forms, has appointed Chris Curtin as chief operating officer. This comes as a promotion from his previous role as executive vice president of Quality Operations. Mr. Curtin will lead the organization responsible for Research & Development, Manufacturing, Quality Assurance, Inventory Management, Quality Control and Analytical Services.   Jim Gregory, chief executive officer of UPM Pharmaceuticals, stated “Ch...